Lista de obras - J M Cooper - Dominio Público Uruguay

A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease

artículo científico publicado en 1994

A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy

scientific journal article

A novel α-synuclein missense mutation in Parkinson disease

artículo científico publicado en 2013

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

artículo científico publicado en 2014

Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing

artículo científico publicado en 1992

Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia

artículo científico publicado en 2010

Antibodies to human optic nerve in Leber's hereditary optic neuropathy

artículo científico publicado en 1995

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up

artículo científico publicado en 2005

Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents.

artículo científico publicado en 2005

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

artículo científico publicado en 1999

Biochemical and molecular aspects of human mitochondrial respiratory chain disorders

artículo científico publicado en 1990

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease ⬇️

artículo científico publicado el 1 de abril de 1992

Cardiac bioenergetics in Friedreich's ataxia

artículo científico publicado en 2003

Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.

artículo científico publicado en 2001

Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes

artículo científico publicado en 2012

Chaperone-mediated autophagy markers in Parkinson disease brains

scientific journal article

Clinical correlates of mitochondrial function in Huntington's disease muscle

artículo científico publicado en 2007

Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia

scientific article published on 01 January 2000

Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy

artículo científico publicado en 2008

Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease

artículo científico publicado en 1994

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

artículo científico publicado en 1994

Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes?

artículo científico publicado en 2006

Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins

artículo científico publicado en 1998

Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms

artículo científico publicado en 2000

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia

artículo científico publicado en 1999

Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease

artículo científico publicado en 1996

Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells

artículo científico publicado en 2004

Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors

artículo científico publicado en 1997

Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies

artículo científico publicado en 2009

Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy

scientific article published on 01 May 1999

G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization

artículo científico publicado en 2012

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

artículo científico publicado en 2012

Human mitochondrial complex I dysfunction ⬇️

artículo científico publicado el 17 de julio de 1992

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

artículo científico publicado en 2013

International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?

artículo científico publicado en 2005

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

artículo científico publicado en 1993

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

artículo científico publicado en 1992

Liver failure associated with mitochondrial DNA depletion

scientific article published on 01 April 1998

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.

artículo científico publicado en 2011

MitBASE : a comprehensive and integrated mitochondrial DNA database. The present status

artículo científico publicado en 2000

Mitochondria in the etiology and pathogenesis of Parkinson's disease

scholarly article by A H Schapira et al published September 1998 in Annals of Neurology

Mitochondria in the etiology and pathogenesis of parkinson's disease

artículo científico publicado en 1998

Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype

artículo científico publicado en 1995

Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.

artículo científico publicado en 1999

Mitochondrial complex I deficiency in Parkinson's disease

artículo científico publicado en 1989

Mitochondrial defect in Huntington's disease caudate nucleus

artículo científico publicado en 1996

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

artículo científico publicado en 2000

Mitochondrial function and parental sex effect in Huntington's disease

artículo científico publicado en 1990

Mitochondrial function in Alzheimer's disease

artículo científico publicado en 1993

Mitochondrial myopathies: clinical defects

artículo científico publicado en 1990

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy

artículo científico publicado en 2010

Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency

artículo científico publicado en 1988

Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases

artículo científico publicado en 1988

Molecular mechanisms in mitochondrial DNA depletion syndrome

artículo científico publicado en 1997

Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion.

artículo científico publicado en 1993

Oxidative-phosphorylation defects in liver of patients with Wilson's disease

scientific article published on 01 August 2000

Platelet mitochondrial function in Leber's hereditary optic neuropathy

artículo científico publicado en 1994

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

artículo científico publicado el 1 de diciembre de 1992

Pramipexole protects against MPTP toxicity in non-human primates

artículo científico publicado en 2006

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

artículo científico publicado en 2004

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons

artículo científico publicado en 2006

Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors

artículo científico publicado en 2008

Quantitation of a mitochondrial DNA deletion in Parkinson's disease

artículo científico publicado el 16 de marzo de 1992

Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells

artículo científico publicado en 2010

Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis

artículo científico publicado en 2009

Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases

artículo científico publicado en 1994

Role of oxidative damage in Friedreich's ataxia

artículo científico publicado en 2004

Sensitivity of respiratory chain activities to lipid peroxidation: effect of vitamin E deficiency

artículo científico publicado en 2001

Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells

artículo científico publicado en 2009

Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice

artículo científico publicado en 2014

The molecular pathology of respiratory-chain dysfunction in human mitochondrial myopathies

artículo científico publicado en 1990

Update of the Human MitBASE database.

artículo científico

Lista de obras de J M Cooper

A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease

A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy

A novel α-synuclein missense mutation in Parkinson disease

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing

Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia

Antibodies to human optic nerve in Leber's hereditary optic neuropathy

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up

Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents.

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Biochemical and molecular aspects of human mitochondrial respiratory chain disorders

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease ⬇️

Cardiac bioenergetics in Friedreich's ataxia

Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.

Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes

Chaperone-mediated autophagy markers in Parkinson disease brains

Clinical correlates of mitochondrial function in Huntington's disease muscle

Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia

Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy

Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes?

Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins

Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia

Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease

Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells

Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors

Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies

Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy

G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

Human mitochondrial complex I dysfunction ⬇️

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

Liver failure associated with mitochondrial DNA depletion

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.

MitBASE : a comprehensive and integrated mitochondrial DNA database. The present status

Mitochondria in the etiology and pathogenesis of Parkinson's disease

Mitochondria in the etiology and pathogenesis of parkinson's disease

Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype

Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.

Mitochondrial complex I deficiency in Parkinson's disease

Mitochondrial defect in Huntington's disease caudate nucleus

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

Mitochondrial function and parental sex effect in Huntington's disease

Mitochondrial function in Alzheimer's disease

Mitochondrial myopathies: clinical defects

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy

Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency

Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases

Molecular mechanisms in mitochondrial DNA depletion syndrome

Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion.

Oxidative-phosphorylation defects in liver of patients with Wilson's disease

Platelet mitochondrial function in Leber's hereditary optic neuropathy

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

Pramipexole protects against MPTP toxicity in non-human primates

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons

Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors

Quantitation of a mitochondrial DNA deletion in Parkinson's disease

Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells

Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis

Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases

Role of oxidative damage in Friedreich's ataxia

Sensitivity of respiratory chain activities to lipid peroxidation: effect of vitamin E deficiency

Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells

Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice

The molecular pathology of respiratory-chain dysfunction in human mitochondrial myopathies

Update of the Human MitBASE database.